In the gene profiles of COVID-19, MYOZ2 is significantly positively correlated to ADAM Metallopeptidase Domain 28 (ADAM28), the biomarker of Activated B cell, C–C Motif Chemokine Ligand 4 (CCL4), the biomarker of Activated CD4 T cell, C1GALT1 Specific Chaperone 1 (C1GALT1C1), the biomarker of Activated CD8 T cell, and many other biomarkers of adaptive immune cells and innate immune cells. This evidence concerns the gene CCL4 and COVID-19.